sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Aug-2014 22:32
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 876-877 out of 877.

<< < 31 | 32 | 33 | 34 | 35 | 36

Public Release: 22-Aug-2012
As TB grows more difficult to control, vaccine candidate to prevent disease enters clinical testing
Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate. The Phase I clinical trial will assess the safety, tolerability and immunogenicity of the vaccine candidate. The study will be conducted by Johnson County Clin-Trials in Lenexa, Kansas. Tuberculosis, which kills more people than any other infectious disease except HIV, has orphaned 10 million children, and costs the global economy an estimated one billion dollars every day.

Contact: Jamie Rosen
jrosen@aeras.org
301-547-2853
Aeras

Public Release: 22-Aug-2012
Genome Research
Scientists reveal how river blindness worm thrives
Scientists at the University of Liverpool have found that the worm which causes River Blindness survives by using a bacterium to provide energy, as well as help 'trick' the body's immune system into thinking it is fighting a different kind of infection.

Contact: Kate Mizen
kate.mizen@liv.ac.uk
0044-151-794-2247
University of Liverpool

Showing releases 876-877 out of 877.

<< < 31 | 32 | 33 | 34 | 35 | 36